参考价: 面议
  • 品牌:
  • 规格:
  • 供货周期:
logo
上海康朗生物科技有限公司
进入展位

产品详情

Quantity size:

0.2ml

Concentration:

1mg/ml 人乳头瘤病毒16型E7抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical 人乳头瘤病毒16型E7抗体cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher 人乳头瘤病毒16型E7抗体affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.

人乳头瘤病毒16型E7抗体Also known as:

E7; HPV16 E7 protein; Human Papilloma Virus; Human papillomavirus type 16 E7; Human papillomavirus type 16 E7; Protein E7; Human Papillomavirus 16 (E7); HPV16 E7; E7 protein (HPV16); VE7_HPV16.

Specificity:

Rabbit Polyclonal IgG, affinity purified by Protein A.

Reacts with: HPV16.

Immunogen: KLH conjugated synthetic peptide derived from HPV16 E7 prote.

Predicted Molecular Weight: 11kDa.

人乳头瘤病毒16型E7抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

l889Ca01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)

kl889Hu01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)

kl889Mu01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)

kl889Ra01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)

kl889Rb51肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)

kl890Ca01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)

kl890Mu01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)

kl890Po01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)

kl890Ra01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)

kl891Hu01花生四烯酸-15-脂加氧酶(ALOX15)多克隆抗体Polyclonal Antibody to Arachidonate-15-Lipoxygenase (ALOX15)

kl895Hu01胰岛素受体(ISR)多克隆抗体Polyclonal Antibody to Insulin Receptor (ISR)

kl895Ra01胰岛素受体(ISR)多克隆抗体Polyclonal Antibody to Insulin Receptor (ISR)

kl896Po01半胱氨酸蛋白酶抑制剂3(CST3)多克隆抗体Polyclonal Antibody to Cystatin 3 (CST3)

kl897Hu01血红蛋白μ(HBμ)多克隆抗体Polyclonal Antibody to Hemoglobin Mu (HBm)

kl899Ca01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)

kl899Mu01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)

kl899Po01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)

kl899Ra01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)

kl899Rb51骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)